New to Bioss? Enjoy 35% of your first order. Use code "FirstOrder35" - Offer valid for new U.S. Customers on direct orders only

CD35 Monoclonal Antibody

Applications

  • WB
  • IHC-P

Reactivity

  • Human
Overview
Catalog # bsm-54759R
Product Name CD35 Monoclonal Antibody
Applications WB, IHC-P
Reactivity Human
Specifications
Conjugation Unconjugated
Host Rabbit
Source Synthetic peptide corresponding to the extracellular domain of human CD35.
Clonality Monoclonal
Clone # 3H19
Isotype IgG
Concentration 1ug/ul
Purification Purified by Protein A.
Storage Buffer Aqueous buffered solution containing 1xTBS (pH7.4), 1%BSA, 40%Glycerol and 0.05% Sodium Azide.
Storage Condition Store at -20°C for 12 months.
Target
Gene ID 1378
Swiss Prot P17927
Subcellular location Membrane
Synonyms C3 binding protein antibody, C3b/C4b receptor antibody, C3BR antibody, C4BR antibody, CD 35 antibody, CD35 antibody, CD35 antigen antibody, complement component (3b/4b) receptor 1 (Knops blood group) antibody, complement component (3b/4b) receptor 1 including Knops blood group system antibody, Complement component receptor 1 antibody, Complement receptor 1 antibody, Complement receptor type 1 antibody, CR 1 antibody, CR1 antibody, CR1_HUMAN antibody, KN antibody, Knops blood group antigen antibody
Background This gene is a member of the receptors of complement activation (RCA) family and is located in the 'cluster RCA' region of chromosome 1. The gene encodes a monomeric single-pass type I membrane glycoprotein found on erythrocytes, leukocytes, glomerular podocytes, and splenic follicular dendritic cells. The Knops blood group system is a system of antigens located on this protein. The protein mediates cellular binding to particles and immune complexes that have activated complement. Decreases in expression of this protein and/or mutations in its gene have been associated with gallbladder carcinomas, mesangiocapillary glomerulonephritis, systemic lupus erythematosus and sarcoidosis. Mutations in this gene have also been associated with a reduction in Plasmodium falciparum rosetting, conferring protection against severe malaria. Alternate allele-specific splice variants, encoding different isoforms, have been characterized. Additional allele specific isoforms, including a secreted form, have been described but have not been fully characterized.
Application Dilution
WB 1:300-5000
IHC-P 1:200-400